Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) has confirmed the completion of its agreement for a US$20 million senior secured debt financing, from SWK.
It was one part of a larger funding phase announced last week and today the company noted that its equity raise – via placing, subscription and retail offering – remains conditional.
The placing and subscription closed last week and the retail offering, through the REX platform, remains open until 10:00 am today.